Combined, this can lead to blood sugar unintentionally dropping to unhealthy or dangerous levels
While the clinical trials have been promising, its potential to manage low testosterone is still being explored
MACE-5 (all-cause death, MI, stroke, heart failure event, coronary revascularisation) 44 events on retatrutide, 52 on placebo: In-study: HR 0.82 (95% CI 0.551.22) On-treatment: HR 0.73 (95% CI 0.471.12) MACE-3 (CV death, MI, stroke) 27 events on retatrutide, 23 on placebo: In-study: HR 1.12 (95% CI 0.641.96) On-treatment: HR 0.92 (95% CI 0.511.65) Lilly states plainly that MACE occurred less frequently than anticipated in both arms
It plays an essential role in battling oxidative stress, neutralising free radicals, as well as supporting our immune system